Skip to main content
. Author manuscript; available in PMC: 2020 Mar 10.
Published in final edited form as: Mol Carcinog. 2016 Jan 6;55(12):2063–2076. doi: 10.1002/mc.22451

Figure 1. JWH-015 inhibits EGF induced proliferation in NSCLC cells.

Figure 1.

(A) NSCLC cell lines- A549, CALU1 and ED1 were subjected to immunoblot to determine expression of CB2 and EGFR. GAPDH is loading control. A549 (B), CALU1 (C) and EDI (D) cells were serum starved and treated with control, JWH-015 (5μM) in absence or presence of EGF (100ng/ml) for 48h and analyzed for viability by MTT assay. P<0.01 (**) as calculated by Student’s t test. Data represent mean ± SD for each experiment repeated three times.